{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where agency_id = \"FDA\" and docket_id = \"FDA-2000-N-0158\" sorted by posted_date descending", "rows": [["FDA-2000-N-0158-0066", "FDA", "FDA-2000-N-0158", "Reference 1, Orthopaedic and Rehabilitation Devices Panel - FDA Executive Summary re Physical Medicine Devices; Reclassification of Iontophoresis Device Intended for Any Other Purposes", "Supporting & Related Material", "Background Material", "2016-08-05T04:00:00Z", 2016, 8, null, null, "2016-08-05T16:18:02Z", null, 0, 0, "0900006482158cf1"], ["FDA-2000-N-0158-0065", "FDA", "FDA-2000-N-0158", "List of References for Final Order- Reclassification of Iontophoresis Devices Intended for Any Other Purposes re Physical Medicine Devices; Reclassification of Iontophoresis Device Intended for Any Other Purposes", "Supporting & Related Material", "Background Material", "2016-08-05T04:00:00Z", 2016, 8, null, null, "2016-08-05T16:16:44Z", null, 0, 0, "0900006482158c8e"], ["FDA-2000-N-0158-0067", "FDA", "FDA-2000-N-0158", "Reference 1a. Orthopaedic and Rehabilitation Devices Panel - 2014 Meeting Materials re Physical Medicine Devices; Reclassification of Iontophoresis Device Intended for Any Other Purposes", "Supporting & Related Material", "Background Material", "2016-08-05T04:00:00Z", 2016, 8, null, null, "2016-08-05T16:19:38Z", null, 0, 0, "0900006482158cf2"], ["FDA-2000-N-0158-0064", "FDA", "FDA-2000-N-0158", "Physical Medicine Devices; Reclassification of Iontophoresis Device Intended for Any Other Purposes", "Rule", "Final Rule", "2016-07-26T04:00:00Z", 2016, 7, "2016-07-26T04:00:00Z", null, "2016-07-26T14:37:46Z", "2016-17609", 0, 0, "09000064821222d9"], ["FDA-2000-N-0158-0057", "FDA", "FDA-2000-N-0158", "Reclassification of Iontophoresis Devices Intended for Any Other\nPurposes", "Proposed Rule", "Notice of Proposed Rulemaking (NPRM)", "2014-09-22T04:00:00Z", 2014, 9, "2014-09-22T04:00:00Z", "2014-12-23T04:59:59Z", "2014-12-23T03:01:11Z", "2014-22453", 0, 0, "0900006481885b66"], ["FDA-2000-N-0158-0058", "FDA", "FDA-2000-N-0158", "List of References reReclassification of Iontophoresis Devices Intended for Any Other Purposes", "Supporting & Related Material", "Background Material", "2014-09-22T04:00:00Z", 2014, 9, null, null, "2014-09-30T16:44:35Z", null, 0, 0, "090000648188626d"], ["FDA-2000-N-0158-0060", "FDA", "FDA-2000-N-0158", "Reference 1-A  - Meeting Materials for the February 21, 2014, meeting of the Orthopaedic and Rehabilitation Devices Panel re Reclassification of Iontophoresis Devices Intended for Any Other Purposes", "Supporting & Related Material", "Background Material", "2014-09-22T04:00:00Z", 2014, 9, null, null, "2014-09-30T16:44:51Z", null, 0, 0, "090000648188626e"], ["FDA-2000-N-0158-0059", "FDA", "FDA-2000-N-0158", "Reference 1 - Meeting Materials for the February 21, 2014, meeting of the Orthopaedic and Rehabilitation Devices Panel re Reclassification of Iontophoresis Devices Intended for Any Other Purposes", "Supporting & Related Material", "Background Material", "2014-09-22T04:00:00Z", 2014, 9, null, null, "2014-09-30T16:44:43Z", null, 0, 0, "090000648188626f"], ["FDA-2000-N-0158-0055", "FDA", "FDA-2000-N-0158", "Attachment 3  re Comment from IOMED Inc., FDA-2000-N-0158-0009", "Supporting & Related Material", "Background Material", "2014-09-15T04:00:00Z", 2014, 9, null, null, "2014-09-15T15:51:17Z", null, 0, 0, "09000064804d1791"], ["FDA-2000-N-0158-0049", "FDA", "FDA-2000-N-0158", "Attachment 14   Didronel  re Comment from Empi Inc FDA-2000-N-0158-0035", "Supporting & Related Material", "Background Material", "2014-09-10T04:00:00Z", 2014, 9, null, null, "2014-09-10T15:14:46Z", null, 0, 0, "09000064804d177f"], ["FDA-2000-N-0158-0046", "FDA", "FDA-2000-N-0158", "Attachment 11   Predcription Drug Product List re Comment from Empi Inc FDA-2000-N-0158-0035", "Supporting & Related Material", "Background Material", "2014-09-10T04:00:00Z", 2014, 9, null, null, "2014-09-10T14:57:08Z", null, 0, 0, "09000064804d1784"], ["FDA-2000-N-0158-0053", "FDA", "FDA-2000-N-0158", "Attachment 2  Comments - Propsed Rule Federal Refigister 69:64313 November 4, 2004  re Comment from IOMED Inc., FDA-2000-N-0158-0009", "Supporting & Related Material", "Background Material", "2014-09-10T04:00:00Z", 2014, 9, null, null, "2014-09-10T20:55:33Z", null, 0, 0, "09000064804d1790"], ["FDA-2000-N-0158-0047", "FDA", "FDA-2000-N-0158", "Attachment 12   Betoptic S Ophthalmic Suspension 0.25 Percent re Comment from Empi Inc FDA-2000-N-0158-0035", "Supporting & Related Material", "Background Material", "2014-09-10T04:00:00Z", 2014, 9, null, null, "2014-09-10T15:05:30Z", null, 0, 0, "09000064804d177b"], ["FDA-2000-N-0158-0052", "FDA", "FDA-2000-N-0158", "Attachment 1  Cover letter re Comment from IOMED Inc., FDA-2000-N-0158-0009", "Supporting & Related Material", "Background Material", "2014-09-10T04:00:00Z", 2014, 9, null, null, "2014-09-10T20:48:15Z", null, 0, 0, "09000064804d178e"], ["FDA-2000-N-0158-0044", "FDA", "FDA-2000-N-0158", "Attachment 8  Treatment of Fungus Infections of the Extremities by the Iontophoresis of Copper Fistula Electrode Current  re Comment from Empi Inc FDA-2000-N-0158-0035", "Supporting & Related Material", "Background Material", "2014-09-10T04:00:00Z", 2014, 9, null, null, "2014-09-10T14:43:03Z", null, 0, 0, "09000064804d1777"], ["FDA-2000-N-0158-0045", "FDA", "FDA-2000-N-0158", "Attachment 10   Affidavit of Donald Maurer re Comment from Empi Inc FDA-2000-N-0158-0035", "Supporting & Related Material", "Background Material", "2014-09-10T04:00:00Z", 2014, 9, null, null, "2014-09-10T14:50:44Z", null, 0, 0, "09000064804d177a"], ["FDA-2000-N-0158-0048", "FDA", "FDA-2000-N-0158", "Attachment 13   Pharmaceutical Product Information Betoptic  Percent re Comment from Empi Inc FDA-2000-N-0158-0035", "Supporting & Related Material", "Background Material", "2014-09-10T04:00:00Z", 2014, 9, null, null, "2014-09-10T15:09:57Z", null, 0, 0, "09000064804d177d"], ["FDA-2000-N-0158-0050", "FDA", "FDA-2000-N-0158", "Attachment 15  Patanol re Comment from Empi Inc FDA-2000-N-0158-0035", "Supporting & Related Material", "Background Material", "2014-09-10T04:00:00Z", 2014, 9, null, null, "2014-09-10T16:34:49Z", null, 0, 0, "09000064804d1780"], ["FDA-2000-N-0158-0032", "FDA", "FDA-2000-N-0158", "Attachment 21 J.Kahn, '' Acetic Acid Iontophoresis for Calcium Deposits, '' Physical Therapy 57/6: 658 June 1977  re Comment from Birch Point Medical Inc FDA 2000-N-0158-0011", "Supporting & Related Material", "Background Material", "2014-09-09T04:00:00Z", 2014, 9, null, null, "2014-09-09T14:43:50Z", null, 0, 0, "09000064804d1751"], ["FDA-2000-N-0158-0043", "FDA", "FDA-2000-N-0158", "Attachment 9   Advertisements re Comment from Empi Inc FDA-2000-N-0158-0035", "Supporting & Related Material", "Background Material", "2014-09-09T04:00:00Z", 2014, 9, null, null, "2014-09-09T21:00:25Z", null, 0, 0, "09000064804d1778"], ["FDA-2000-N-0158-0037", "FDA", "FDA-2000-N-0158", "Attachment 2 Civil Action No. 83-3314 STIPULATION AND ORDER OF DISMISSAL re Comment from Empi Inc FDA-2000-N-0158-0035", "Supporting & Related Material", "Background Material", "2014-09-09T04:00:00Z", 2014, 9, null, null, "2014-09-09T17:13:19Z", null, 0, 0, "09000064804d1768"], ["FDA-2000-N-0158-0033", "FDA", "FDA-2000-N-0158", "Attachment 22  M-D-D-I Reports November 13, 1978 , at 2 re Comment from Birch Point Medical Inc FDA 2000-N-0158-0011", "Supporting & Related Material", "Background Material", "2014-09-09T04:00:00Z", 2014, 9, null, null, "2014-09-09T15:03:01Z", null, 0, 0, "09000064804d1753"], ["FDA-2000-N-0158-0041", "FDA", "FDA-2000-N-0158", "Attachment 6  APPENDIX TO PLAINTIFF'S MOTION FOR SUMMARY JUDGMENT  re Comment from Empi Inc FDA-2000-N-0158-0035", "Supporting & Related Material", "Background Material", "2014-09-09T04:00:00Z", 2014, 9, null, null, "2014-09-09T20:08:51Z", null, 0, 0, "09000064804d1773"], ["FDA-2000-N-0158-0042", "FDA", "FDA-2000-N-0158", "Attachment 7  Fistula Electrode - '' For Treatment of Fisculae with Positive Galvanic Current  re Comment from Empi Inc FDA-2000-N-0158-0035", "Supporting & Related Material", "Background Material", "2014-09-09T04:00:00Z", 2014, 9, null, null, "2014-09-09T20:16:59Z", null, 0, 0, "09000064804d1775"], ["FDA-2000-N-0158-0040", "FDA", "FDA-2000-N-0158", "Attachment 5  Use of Low-Voltage Electrotherapy and Electromygraphy in Physical Thearapy re Comment from Empi Inc FDA-2000-N-0158-0035", "Supporting & Related Material", "Background Material", "2014-09-09T04:00:00Z", 2014, 9, null, null, "2014-09-09T20:02:44Z", null, 0, 0, "09000064804d1770"], ["FDA-2000-N-0158-0038", "FDA", "FDA-2000-N-0158", "Attachment 3 Civil Action No. 83-3314  November 19 , 1984 STIPULATION AND ORDER OF DISMISSAL re Comment from Empi Inc FDA-2000-N-0158-0035", "Supporting & Related Material", "Background Material", "2014-09-09T04:00:00Z", 2014, 9, null, null, "2014-09-09T19:48:28Z", null, 0, 0, "09000064804d1766"], ["FDA-2000-N-0158-0039", "FDA", "FDA-2000-N-0158", "Attachment 4 Affidavit Ervin Larrie Rhodes  re Comment from Empi Inc FDA-2000-N-0158-0035", "Supporting & Related Material", "Background Material", "2014-09-09T04:00:00Z", 2014, 9, null, null, "2014-09-09T19:56:25Z", null, 0, 0, "09000064804d176e"], ["FDA-2000-N-0158-0034", "FDA", "FDA-2000-N-0158", "Attachment 23 Iomed 10-K June 30,2000 excerpts re Comment from Birch Point Medical Inc FDA 2000 N 0158 0011", "Supporting & Related Material", "Background Material", "2014-09-09T04:00:00Z", 2014, 9, null, null, "2014-09-09T15:03:22Z", null, 0, 0, "09000064804d1754"], ["FDA-2000-N-0158-0031", "FDA", "FDA-2000-N-0158", "Attachment 19  V.Payne. '' My Results with Ionization Treatment in Nasal Allergy, '' Archives of Physical Therapy, X-Ray, Radium 18: 598 September 1937 re Comment from Birch Point Medical Inc FDA 2000-N-0158-0011", "Supporting & Related Material", "Background Material", "2014-09-09T04:00:00Z", 2014, 9, null, null, "2014-09-09T14:43:39Z", null, 0, 0, "09000064804d174e"], ["FDA-2000-N-0158-0030", "FDA", "FDA-2000-N-0158", "Attachment 16 Advertisement  DALLONS 1400MG 1964 re Comment from Birch Point Medical Inc FDA 2000-N-0158-0011", "Supporting & Related Material", "Background Material", "2014-09-09T04:00:00Z", 2014, 9, null, null, "2014-09-09T14:43:24Z", null, 0, 0, "09000064804d1749"], ["FDA-2000-N-0158-0036", "FDA", "FDA-2000-N-0158", "Attachment 1 Iontophoresis re Comment from Empi Inc FDA-2000-N-0158-0035", "Supporting & Related Material", "Background Material", "2014-09-09T04:00:00Z", 2014, 9, null, null, "2014-09-09T16:27:23Z", null, 0, 0, "09000064804d176a"], ["FDA-2000-N-0158-0026", "FDA", "FDA-2000-N-0158", "Attachment 15 Advertisement TECA SP-5 1963 re Comment from Birch Point Medical Inc FDA 2000-N-0158-0011", "Supporting & Related Material", "Background Material", "2014-09-08T04:00:00Z", 2014, 9, null, null, "2014-09-08T19:52:53Z", null, 0, 0, "09000064804d1748"], ["FDA-2000-N-0158-0029", "FDA", "FDA-2000-N-0158", "Attachment 20 K. Harpuder, ''Electrophoretic Therapy: Problems and Value, '' N.Y. State Jour of Medicine 38/3: 176 February 1938 re Comment from Birch Point Medical Inc FDA 2000-N-0158-0011", "Supporting & Related Material", "Background Material", "2014-09-08T04:00:00Z", 2014, 9, null, null, "2014-09-08T20:40:50Z", null, 0, 0, "09000064804d174f"], ["FDA-2000-N-0158-0025", "FDA", "FDA-2000-N-0158", "Attachment 14 Advertisement MARK V 1963 re Comment from Birch Point Medical Inc FDA 2000-N-0158-0011", "Supporting & Related Material", "Background Material", "2014-09-08T04:00:00Z", 2014, 9, null, null, "2014-09-08T19:42:24Z", null, 0, 0, "09000064804d1746"], ["FDA-2000-N-0158-0027", "FDA", "FDA-2000-N-0158", "Attachment 17 Advertisement TECA SP-2 1964 re Comment from Birch Point Medical Inc FDA 2000-N-0158-0011", "Supporting & Related Material", "Background Material", "2014-09-08T04:00:00Z", 2014, 9, null, null, "2014-09-08T20:08:45Z", null, 0, 0, "09000064804d174b"], ["FDA-2000-N-0158-0028", "FDA", "FDA-2000-N-0158", "Attachment 18 Abramson et al. , '' Skin Reactions. I. Mechanism of Histamine Iontophoresis from Aqueous Media, '' Archives of Physical Therapy, X-Ray, Radium 18: 327 June 1937  re Comment from Birch Point Medical Inc FDA 2000-N-0158-0011", "Supporting & Related Material", "Background Material", "2014-09-08T04:00:00Z", 2014, 9, null, null, "2014-09-08T20:18:01Z", null, 0, 0, "09000064804d174c"], ["FDA-2000-N-0158-0015", "FDA", "FDA-2000-N-0158", "Attachment 4 Affidavit of Luther C. Kloth re Comment from Birch Point Medical Inc FDA 2000-N-0158-0011", "Supporting & Related Material", "Background Material", "2014-09-05T04:00:00Z", 2014, 9, null, null, "2014-09-05T20:37:58Z", null, 0, 0, "09000064804d175c"], ["FDA-2000-N-0158-0020", "FDA", "FDA-2000-N-0158", "Attachment 9  Advertisement: TECA SP-5 1953 re Comment from Birch Point Medical Inc", "Supporting & Related Material", "Background Material", "2014-09-05T04:00:00Z", 2014, 9, null, null, "2014-09-05T20:38:30Z", null, 0, 0, "09000064804d172d"], ["FDA-2000-N-0158-0018", "FDA", "FDA-2000-N-0158", "Attachment 7 Affidavit of  Danny D.Smith re Comment from Birch Point Medical Inc FDA 2000-N-0158-0011", "Supporting & Related Material", "Background Material", "2014-09-05T04:00:00Z", 2014, 9, null, null, "2014-09-05T20:17:10Z", null, 0, 0, "09000064804d1758"], ["FDA-2000-N-0158-0013", "FDA", "FDA-2000-N-0158", "Attachment 2 American Medical Association, Handbook of Physical Therapy 3d ed. 1939 re Comment from Birch Point Medical Inc FDA 2000-N-0158- 0011", "Supporting & Related Material", "Background Material", "2014-09-05T04:00:00Z", 2014, 9, null, null, "2014-09-05T20:36:19Z", null, 0, 0, "09000064804d1760"], ["FDA-2000-N-0158-0021", "FDA", "FDA-2000-N-0158", "Attachment 10 Advertisement: TECA SP-2 1954 re Comment from Birch Point Medical Inc re FDA 2000-N-0158-0011", "Supporting & Related Material", "Background Material", "2014-09-05T04:00:00Z", 2014, 9, null, null, "2014-09-05T20:34:09Z", null, 0, 0, "09000064804d1740"], ["FDA-2000-N-0158-0022", "FDA", "FDA-2000-N-0158", "Attachment 11 Advertisement TECA CD4 P5 1958 re Comment from Birch Point Medical Inc FDA 2000-N-0158- 0011", "Supporting & Related Material", "Background Material", "2014-09-05T04:00:00Z", 2014, 9, null, null, "2014-09-05T20:47:31Z", null, 0, 0, "09000064804d1741"], ["FDA-2000-N-0158-0019", "FDA", "FDA-2000-N-0158", "Attachment 8 Merck Brochure for Mecholyl 1941 re Comment from Birch Point Medical Inc FDA 2000-N-0158-0011", "Supporting & Related Material", "Background Material", "2014-09-05T04:00:00Z", 2014, 9, null, null, "2014-09-05T20:24:29Z", null, 0, 0, "09000064804d1756"], ["FDA-2000-N-0158-0024", "FDA", "FDA-2000-N-0158", "Attachment 13 Advertisement PC 1118,  PC 1120  1958 re Comment from Birch Point Medical Inc FDA 2000-N-0158-0011", "Supporting & Related Material", "Background Material", "2014-09-05T04:00:00Z", 2014, 9, null, null, "2014-09-05T21:00:52Z", null, 0, 0, "09000064804d1745"], ["FDA-2000-N-0158-0012", "FDA", "FDA-2000-N-0158", "Attachment 1 Advertisement PC 2918 2919 2900 2901 1963 re Comment from Birch Point Medical Inc FDA-2000-N-0158-0011", "Supporting & Related Material", "Background Material", "2014-09-05T04:00:00Z", 2014, 9, null, null, "2014-09-05T20:35:46Z", null, 0, 0, "09000064804d1765"], ["FDA-2000-N-0158-0017", "FDA", "FDA-2000-N-0158", "Attachment 6 Affidavit of Neil I. Spielholz re Comment from Birch Point Medical Inc FDA 2000-N-0158-0011", "Supporting & Related Material", "Background Material", "2014-09-05T04:00:00Z", 2014, 9, null, null, "2014-09-05T20:09:49Z", null, 0, 0, "09000064804d1759"], ["FDA-2000-N-0158-0023", "FDA", "FDA-2000-N-0158", "Attachment 12  Advertisement TOMAC 1958 re Comment from Birch Point Medical Inc FDA 2000-N-0158-0011", "Supporting & Related Material", "Background Material", "2014-09-05T04:00:00Z", 2014, 9, null, null, "2014-09-05T20:53:54Z", null, 0, 0, "09000064804d1743"], ["FDA-2000-N-0158-0016", "FDA", "FDA-2000-N-0158", "Attachment 5 Joseph Kahn, Principles and Practice of Electrotherapy 1987 excerpt re Comment from Birch Point Medical Inc FDA 2000-N-0158-0011", "Supporting & Related Material", "Background Material", "2014-09-05T04:00:00Z", 2014, 9, null, null, "2014-09-05T20:38:13Z", null, 0, 0, "09000064804d175b"], ["FDA-2000-N-0158-0014", "FDA", "FDA-2000-N-0158", "Attachment 3 Linda Amrein et al., \" Use of Low Voltage Electrotherapy and Electromyography in Physical Therapy, '' Physical Therapy 51/12: 1283 1971 re Comment from Birch Point Medical Inc FDA 2000-N-0158-0011", "Supporting & Related Material", "Background Material", "2014-09-05T04:00:00Z", 2014, 9, null, null, "2014-09-05T20:37:11Z", null, 0, 0, "09000064804d175e"], ["FDA-2000-N-0158-0006", "FDA", "FDA-2000-N-0158", "Memorandum from FDA/CDRH Extension of Comment Period to December 19, 2000 (Physical Medicine Devices; Revision of the Identification of the Ionotophoresis Device), dated October 27, 2000", "Other", "Memorandum", "2014-09-03T04:00:00Z", 2014, 9, "2014-09-03T04:00:00Z", null, "2024-10-29T19:51:32Z", null, 0, 0, "09000064804d1723"], ["FDA-2000-N-0158-0010", "FDA", "FDA-2000-N-0158", "Shipping Label re Comment from IOMED Inc., FDA-2000-N-0158-0009", "Supporting & Related Material", "Background Material", "2014-08-20T04:00:00Z", 2014, 8, null, null, "2014-09-03T18:10:08Z", null, 0, 0, "09000064804d172c"], ["FDA-2000-N-0158-0005", "FDA", "FDA-2000-N-0158", "Enclosure  re Comment from Wescor Inc, FDA-2000-N-0158-0004", "Supporting & Related Material", "Background Material", "2014-08-20T04:00:00Z", 2014, 8, null, null, "2014-09-03T18:09:50Z", null, 0, 0, "09000064804d171f"], ["FDA-2000-N-0158-0008", "FDA", "FDA-2000-N-0158", "Enclosure 1 re Comment from Cystic Fibrosis Foundation (CFF) FDA-2000-N-0158-0007", "Supporting & Related Material", "Background Material", "2014-08-20T04:00:00Z", 2014, 8, null, null, "2014-09-03T18:09:59Z", null, 0, 0, "09000064804d1726"], ["FDA-2000-N-0158-0002", "FDA", "FDA-2000-N-0158", "Medical Devices; Reclassification of the lontophoresis Device", "Notice", "Notice of Intent", "2004-11-04T05:00:00Z", 2004, 11, "2004-11-04T05:00:00Z", "2005-02-03T04:59:59Z", "2025-06-11T23:54:22Z", "04-24591", 0, 0, "09000064804d178a"], ["FDA-2000-N-0158-0003", "FDA", "FDA-2000-N-0158", "Medical Devices; Revision of the Identification of the lontophoresis Device; Withdrawal", "Notice", "Withdrawal", "2004-11-04T05:00:00Z", 2004, 11, "2004-11-04T05:00:00Z", null, "2025-06-11T23:55:13Z", "04-24590", 0, 0, "09000064804d178b"], ["FDA-2000-N-0158-0001", "FDA", "FDA-2000-N-0158", "Physical Medicine Devices; Revision of the Identification of the Ionotophoresis Device", "Proposed Rule", "Notice of Proposed Rulemaking (NPRM)", "2000-09-01T04:00:00Z", 2000, 9, "2000-08-22T04:00:00Z", "2000-11-21T04:59:59Z", "2025-06-11T23:53:28Z", "00-21251", 0, 0, "09000064804d1701"]], "truncated": false, "filtered_table_rows_count": 56, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"agency_id\" = :p0 and \"docket_id\" = :p1 order by posted_date desc limit 101", "params": {"p0": "FDA", "p1": "FDA-2000-N-0158"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-2000-N-0158", "results": [{"value": "FDA", "label": "FDA", "count": 56, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2000-N-0158", "selected": true}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-2000-N-0158", "results": [{"value": "Supporting & Related Material", "label": "Supporting & Related Material", "count": 50, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2000-N-0158&document_type=Supporting+%26+Related+Material", "selected": false}, {"value": "Notice", "label": "Notice", "count": 2, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2000-N-0158&document_type=Notice", "selected": false}, {"value": "Proposed Rule", "label": "Proposed Rule", "count": 2, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2000-N-0158&document_type=Proposed+Rule", "selected": false}, {"value": "Other", "label": "Other", "count": 1, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2000-N-0158&document_type=Other", "selected": false}, {"value": "Rule", "label": "Rule", "count": 1, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2000-N-0158&document_type=Rule", "selected": false}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-2000-N-0158", "results": [{"value": 2014, "label": 2014, "count": 49, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2000-N-0158&posted_year=2014", "selected": false}, {"value": 2016, "label": 2016, "count": 4, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2000-N-0158&posted_year=2016", "selected": false}, {"value": 2004, "label": 2004, "count": 2, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2000-N-0158&posted_year=2004", "selected": false}, {"value": 2000, "label": 2000, "count": 1, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2000-N-0158&posted_year=2000", "selected": false}], "truncated": false}}, "suggested_facets": [{"name": "subtype", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2000-N-0158&_facet=subtype"}, {"name": "posted_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2000-N-0158&_facet=posted_date"}, {"name": "posted_month", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2000-N-0158&_facet=posted_month"}, {"name": "comment_start_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2000-N-0158&_facet=comment_start_date"}, {"name": "posted_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2000-N-0158&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2000-N-0158&_facet_date=comment_start_date"}, {"name": "comment_end_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2000-N-0158&_facet_date=comment_end_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2000-N-0158&_facet_date=last_modified"}], "next": null, "next_url": null, "private": false, "allow_execute_sql": true, "query_ms": 693.3208859991282, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}